about
Advanced drug delivery and targeting technologies for the ocular diseasesNanoparticles for biomedical imaging: fundamentals of clinical translationIntraocular pressure changes: an important determinant of the biocompatibility of intravitreous implantsConjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug deliveryRecent perspectives in ocular drug delivery.Chitosan nanoparticles for drug delivery to the eye.NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS.Impacts of nanomedicines in ocular pharmacotherapyTopical delivery of ocular therapeutics: carrier systems and physical methods.The role of nanotechnology in control of human diseases: perspectives in ocular surface diseases.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy.Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier.Utility and Potential Application of Nanomaterials in MedicineFunctional Nanomaterials for Multifarious NanomedicineHydrogel Contact Lens for Extended Delivery of Ophthalmic DrugsA Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome
P2860
Q26747220-93CAE759-1338-442E-BA0E-6F03E0DD05FEQ28385644-F38CE340-4827-4987-8C34-184FB8CAF7BDQ28478420-06F6E491-DA6B-4513-AFCC-BF17353B8783Q35043797-83297E58-E2CC-4840-92DB-D2CEEDD5117BQ37256549-501367E9-CBA1-47F2-BD9B-6577B81C3254Q37416144-A2891B0C-E170-4632-97BD-1C23DF81B172Q37776418-A729DAA7-67B9-4957-B9AC-7140BD854BB9Q38107200-303E2060-C645-4B8A-9948-220711744C89Q38196446-47E2A8FF-AFBF-4C8C-B272-2AA621EE1F5AQ38550131-D8F6DB48-42FA-4C6C-8979-63FE3059779AQ38648168-768F4067-3F6B-4412-BE31-A1560811F617Q48735724-973ECE11-007B-40CF-896C-3F0C1E32E279Q50036998-2AD3CD92-0468-40EB-9A09-4F77651CD1E9Q55471051-9124CF84-9842-4107-BD21-1F94019CDE10Q57340460-FEBBB3EA-9DC2-425A-AAE1-12C55E0D9176Q57340480-A01C1401-28B1-412A-9E09-2D29ACC6B395Q58688405-12A2DB50-2E0F-47AC-ABEC-4056413124BBQ58855623-EAEE3049-F172-4D29-919D-1B344DF8B721
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Ocular drug delivery: nanomedicine applications.
@en
type
label
Ocular drug delivery: nanomedicine applications.
@en
prefLabel
Ocular drug delivery: nanomedicine applications.
@en
P2860
P356
P1433
P1476
Ocular drug delivery: nanomedicine applications.
@en
P2093
Annick Ludwig
Jo Vandervoort
P2860
P356
10.2217/17435889.2.1.11
P577
2007-02-01T00:00:00Z